An evaluation of topical mupirocin in moderately severe primary and secondary skin infections

J Buchvald1

  • 1Kl Dermatovenerologicka FN, Bratislava, Czechoslovakia.

Insights

Topical mupirocin effectively treated skin infections in 36 patients over five days. The antibiotic achieved significant lesion improvement in 75% and bacterial eradication in over 83%, with no reported side effects.

Area of Science:

  • Dermatology
  • Infectious Diseases
  • Bacteriology

Background:

  • Primary and secondary skin infections pose a significant clinical challenge.
  • Bacterial pathogens, particularly staphylococci, are frequently implicated in skin infections.
  • Topical antimicrobial agents are a cornerstone of treatment for superficial skin infections.

Purpose of the Study:

  • To evaluate the efficacy and safety of topical mupirocin for treating primary and secondary skin infections.
  • To assess the rate of clinical resolution and bacterial eradication in patients receiving mupirocin.
  • To identify the common bacterial species involved in the treated infections.

Main Methods:

  • A study involving 36 patients with moderately severe primary and secondary skin infections.
  • Treatment consisted of topical mupirocin applied twice daily for five days.
  • Clinical outcomes (lesion resolution/improvement) and bacterial eradication rates were assessed.

Main Results:

  • Resolution or much improvement of skin lesions was observed in 75.0% of patients.
  • Bacterial eradication was achieved in 83.9% of cases.
  • Penicillin-resistant and penicillin-sensitive staphylococci were the most frequently identified pathogens.

Conclusions:

  • Topical mupirocin demonstrates high efficacy in treating primary and secondary skin infections.
  • The treatment is well-tolerated, with no adverse effects reported in this patient cohort.
  • Mupirocin is an effective option for eradicating staphylococcal infections of the skin.

Related Concept Videos

Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Surface Membrane Barriers01:18

Surface Membrane Barriers

The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Acne Infection01:27

Acne Infection

Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...